Risk of second cancer after lymphohematopoietic neoplasm

International Journal of Cancer

Volumn 129, Issue 4, 2011, Pages 910-919

  Royle, Jill S ^a   Baade, Peter ^b,c   Joske, David ^d   Fritschi, Lin ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

cohort; leukemia; lymphoma; myeloma; second cancer

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONNECTIVE TISSUE CANCER; CONTROLLED STUDY; EYE CANCER; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; KAPOSI SARCOMA; LIP CANCER; LYMPHOHEMATOPOIETIC NEOPLASM; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA; PERIPHERAL NERVE CANCER; PHARYNX CANCER; PLASMACYTOMA; PRIORITY JOURNAL; SECOND CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; AUSTRALIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK FACTORS;

EID: 79959728919     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25706     Document Type: Article

References (33)

1. AIHW, AACR. Cancer in Australia 2001. AIHW cat no CAN 23. Canberra: AIHW (Cancer Series no. 28), 2004.
2. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M,. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995; 310: 1491-5.
3. Groves FD, Linet MS, Travis LB, Devesa SS,. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-51. (Pubitemid 30627732)
4. Thomas RK, Re D, Zander T, Wolf J, Diehl V,. Epidemiology and etiology of Hodgkin's lymphoma. Ann Oncol 2002; 13 (Suppl 4): 147-52. (Pubitemid 35363766)
5. Suarez F, Lortholary O, Hermine O, Lecuit M,. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034-44.
6. Linet MS, Devesa SS, Morgan GJ,. The leukemias. In:, Schottenfeld D, Fraumeni JF, Jr., eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006. 841-71.
7. De Roos AJ, Baris D, Weiss NS, Herrinton LJ,. Multiple myeloma. In:, Schottenfeld D, Fraumeni JF, Jr., eds. Cancer epidemiology and prevention, 3rd. edn. New York: Oxford University Press, 2006. 919-45.
8. Greene MH, Wilson J,. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985; 68: 191-217. (Pubitemid 16233731)
9. Travis LB, Curtis RE, Hankey BF, Fraumeni JF, Jr., Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84: 1422-7.
10. Mellemgaard A, Geisler CH, Storm HH,. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 1994; 53: 218-22. (Pubitemid 24347966)
11. Brennan P, Coates M, Armstrong B, Colin D, Boffetta P,. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 2000; 82: 1344-7. (Pubitemid 30145356)
12. Hisada M, Biggar RJ, Greene MH, Fraumeni JF, Jr., Travis LB,. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 98: 1979-81.
13. Dong C, Hemminki K,. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 2001; 85: 997-1005. (Pubitemid 33016003)
14. Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93: 159-66. (Pubitemid 41078800)
15. Schollkopf C, Rosendahl D, Rostgaard K, Pipper C, Hjalgrim H,. Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer 2007; 121: 151-6. (Pubitemid 46753863)
16. Hemminki K, Lenner P, Sundquist J, Bermejo JL,. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol 2008; 26: 1850-7.
17. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D,. Cancer incidence in five continents. IARC Publications No. 155. Lyon, 2003.
18. AIHW, AACR. Cancer in Australia: an overview, 2008. Canbera: AIHW, 2008.
19. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister, TA, Linch DC,. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498-509. (Pubitemid 30078531)
20. Travis LB, Curtis RE, Boice JD, Jr., Hankey BF, Fraumeni JF, Jr., Second cancers following non-Hodgkin's lymphoma. Cancer 1991; 67: 2002-9.
21. Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, Tucker MA, Fraumeni JF, Jr., et al. Second cancers among long- term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993; 85: 1932-7. (Pubitemid 23354032)
22. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ,. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 1997; 75: 116-23. (Pubitemid 27007283)
23. English DR, Armstrong BK, Kricker A, Fleming C,. Sunlight and cancer. Cancer Causes Control 1997; 8: 271-83. (Pubitemid 27297796)
24. Levi F, Randimbison L, Te VC, La Vecchia C,. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847-50. (Pubitemid 26401911)
25. Hartley BE, Searle AE, Breach NM, Rhys-Evans PH, Henk JM,. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 1996; 110: 694-5. (Pubitemid 26237589)
26. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97: 199-209. (Pubitemid 40277370)
27. McKenna DB, Stockton D, Brewster DH, Doherty VR,. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003; 88: 74-8. (Pubitemid 36241221)
28. Mudie NY, Swerdlow AJ, Higgins CD, Smith P, Qiao Z, Hancock BW, Hoskin PJ, Linch DC,. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. J Clin Oncol 2006; 24: 1568-74. (Pubitemid 46638780)
29. Travis LB, Curtis RE, Glimelius B, Holowaty EJ, van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, Gospodarowicz MK, Wacholder S, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995; 87: 524-30.
30. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R,. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312-25. (Pubitemid 24056405)
31. Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, Ultmann JE,. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995; 87: 732-41.
32. Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ,. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87: 3625-32. (Pubitemid 26129590)
33. Siskind V, Aitken J, Green A, Martin N,. Sun exposure and interaction with family history in risk of melanoma, Queensland, Australia. Int J Cancer 2002; 97: 90-5.